216 related articles for article (PubMed ID: 18680566)
1. Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.
Lamb D; Schüttelkopf AW; van Aalten DM; Brighty DW
Retrovirology; 2008 Aug; 5():70. PubMed ID: 18680566
[TBL] [Abstract][Full Text] [Related]
2. Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.
Lamb D; Mirsaliotis A; Kelly SM; Brighty DW
J Biol Chem; 2009 Mar; 284(10):6575-84. PubMed ID: 19114713
[TBL] [Abstract][Full Text] [Related]
3. An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.
Piñón JD; Kelly SM; Price NC; Flanagan JU; Brighty DW
J Virol; 2003 Mar; 77(5):3281-90. PubMed ID: 12584351
[TBL] [Abstract][Full Text] [Related]
4. Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry.
Mirsaliotis A; Lamb D; Brighty DW
J Virol; 2008 May; 82(10):4965-73. PubMed ID: 18305034
[TBL] [Abstract][Full Text] [Related]
5. An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function.
Mirsaliotis A; Nurkiyanova K; Lamb D; Kuo CS; Brighty DW
J Gen Virol; 2007 Feb; 88(Pt 2):660-669. PubMed ID: 17251585
[TBL] [Abstract][Full Text] [Related]
6. Charge-surrounded pockets and electrostatic interactions with small ions modulate the activity of retroviral fusion proteins.
Lamb D; Schüttelkopf AW; van Aalten DM; Brighty DW
PLoS Pathog; 2011 Feb; 7(2):e1001268. PubMed ID: 21304939
[TBL] [Abstract][Full Text] [Related]
7. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo.
Gatot JS; Callebaut I; Mornon JP; Portetelle D; Burny A; Kerkhofs P; Kettmann R; Willems L
J Biol Chem; 1998 May; 273(21):12870-80. PubMed ID: 9582317
[TBL] [Abstract][Full Text] [Related]
8. Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.
Mirsaliotis A; Nurkiyanova K; Lamb D; Woof JM; Brighty DW
J Virol; 2007 Jun; 81(11):6019-31. PubMed ID: 17376912
[TBL] [Abstract][Full Text] [Related]
9. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
Gatot JS; Callebaut I; Van Lint C; Demonté D; Kerkhofs P; Portetelle D; Burny A; Willems L; Kettmann R
J Virol; 2002 Aug; 76(16):7956-67. PubMed ID: 12134000
[TBL] [Abstract][Full Text] [Related]
10. Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses.
Mirsaliotis A; Nurkiyanova K; Lamb D; Kuo CW; Brighty DW
J Biol Chem; 2007 Dec; 282(50):36724-35. PubMed ID: 17940280
[TBL] [Abstract][Full Text] [Related]
11. Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases.
Sperka T; Miklóssy G; Tie Y; Bagossi P; Zahuczky G; Boross P; Matúz K; Harrison RW; Weber IT; Tözsér J
J Gen Virol; 2007 Jul; 88(Pt 7):2052-2063. PubMed ID: 17554040
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
13. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
Johnston ER; Albritton LM; Radke K
J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
[TBL] [Abstract][Full Text] [Related]
14. De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.
Sundaram R; Lynch MP; Rawale SV; Sun Y; Kazanji M; Kaumaya PT
J Biol Chem; 2004 Jun; 279(23):24141-51. PubMed ID: 15060075
[TBL] [Abstract][Full Text] [Related]
15. Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure.
Maerz AL; Center RJ; Kemp BE; Kobe B; Poumbourios P
J Virol; 2000 Jul; 74(14):6614-21. PubMed ID: 10864675
[TBL] [Abstract][Full Text] [Related]
16. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.
Rosenberg AR; Delamarre L; Pique C; Pham D; Dokhélar MC
J Virol; 1997 Oct; 71(10):7180-6. PubMed ID: 9311790
[TBL] [Abstract][Full Text] [Related]
17. The trimer-of-hairpins motif in membrane fusion: Visna virus.
Malashkevich VN; Singh M; Kim PS
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8502-6. PubMed ID: 11447278
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs.
Pluta A; Albritton LM; Rola-Łuszczak M; Kuźmak J
Retrovirology; 2018 Jan; 15(1):2. PubMed ID: 29310678
[TBL] [Abstract][Full Text] [Related]
19. Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.
Kim FJ; Seiliez I; Denesvre C; Lavillette D; Cosset FL; Sitbon M
J Biol Chem; 2000 Aug; 275(31):23417-20. PubMed ID: 10851227
[TBL] [Abstract][Full Text] [Related]
20. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
Bewley CA; Louis JM; Ghirlando R; Clore GM
J Biol Chem; 2002 Apr; 277(16):14238-45. PubMed ID: 11859089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
